Physician
Allergy & Asthma Associates of Mi PC
Allergy & Asthma Associates of Mi PC was paid $15.95M by Medicaid between Jan 2018 and Dec 2024, across 42 billing codes. Its largest line is J2357, Injection, omalizumab, 5 mg — 41% of everything it billed.
33Billing provider infoALLERGY & ASTHMA ASSOCIATES OF MI PC
ROYAL OAK, MI 48073
ROYAL OAK, MI 48073
33aNPI1871526459assigned 07/08/2006
33bProvider typeAllergy & Immunology Physician
28Total paid$15.95M
24GClaims275,214
24DCodes billed42
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Allergy & Immunology Physician providers in Michigan
Rank by total paid#1 of 32
Median peer was paid$204K
This provider vs. median78×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 42,344 | $2.10M | |
| 2019 | 40,721 | $1.95M | |
| 2020 | 35,104 | $2.04M | |
| 2021 | 40,966 | $2.48M | |
| 2022 | 38,750 | $2.39M | |
| 2023 | 42,116 | $2.61M | |
| 2024incomplete | 35,213 | $2.39M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J2357 | Injection, omalizumab, 5 mg | 41% | 6,581 | 4,383 | $6.50M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 49,974 | 46,404 | $2.32M |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 13% | 10,849 | 10,767 | $2.06M |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 9.3% | 11,861 | 11,668 | $1.49M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.9% | 9,984 | 9,924 | $938K |
| 94060 | 4.4% | 25,518 | 25,059 | $702K | |
| 95117 | 4.4% | 108,726 | 36,048 | $698K | |
| 95024 | 3.5% | 7,376 | 7,335 | $553K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 2,237 | 2,173 | $155K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 11,074 | 8,689 | $144K |
| 95115 | <1% | 19,435 | 6,711 | $103K | |
| 96401 | <1% | 1,246 | 995 | $98K |
30 more codes
| J0517 | Injection, benralizumab, 1 mg | <1% | 26 | $56K |
| 95044 | <1% | 277 | $55K | |
| 90674 | <1% | 679 | $18K | |
| 94726 | <1% | 480 | $16K | |
| 94729 | <1% | 450 | $16K | |
| G0008 | Administration of influenza virus vaccine | <1% | 1,072 | $10K |
| 94010 | <1% | 264 | $5K | |
| 90688 | <1% | 230 | $4K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 52 | $3K |
| 94664 | <1% | 1,168 | $3K | |
| 90661 | <1% | 85 | $3K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 467 | $2K |
| 90756 | <1% | 68 | $2K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 118 | $1K |
| 95076 | <1% | 13 | $883.12 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 34 | $652.59 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 31 | $246.42 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | <1% | 586 | $1.11 |
| G9907 | Documentation of medical reason(s) for not providing tobacco cessation intervention on the date of the encounter or within the previous 12 months (e.g., limited life expectancy, other medical reason) | <1% | 41 | $0.20 |
| G8484 | Influenza immunization was not administered, reason not given | 0% | 140 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 1,055 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 745 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 812 | $0.00 |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 236 | $0.00 |
| 4040F | 0% | 176 | $0.00 | |
| 4004F | 0% | 53 | $0.00 | |
| 1123F | 0% | 70 | $0.00 | |
| C9399 | Unclassified drugs or biologicals | 0% | 40 | $0.00 |
| 1036F | 0% | 802 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 83 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPATEL, AMRISH (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Spine Institute on the Emerald Coast | Destin, FL | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.